This seminar is supported by Bristol-Myers Squibb and Celgene as Associate Sponsors.

This seminar will provide a timely opportunity for delegates to discuss the commissioning and delivery of cancer care in the reformed NHS.

Sessions at this event will focus on the improvement of cancer services across each of the NHS domains, the role of NHS England, Clinical Commissioning Groups and Clinical Senates in commissioning cancer care, and next steps for improving public health and awareness.

With the Cancer Drugs Fund to be extended until 2016, attendees will also consider key issues surrounding the provision of and access to treatments, and the impact of increased funding for research.